These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6970038)

  • 21. Tumor growth inhibitory and natural suppressor activities of murine bone marrow cells: a comparative study.
    Seledtsov VI; Taraban VY; Seledtsova GV; Samarin DM; Avdeev IV; Senyukov VV; Kozlov VA
    Cell Immunol; 1997 Nov; 182(1):12-9. PubMed ID: 9427805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
    Alleva DG; Burger CJ; Elgert KD
    Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation between cytotoxic and suppressor activities of human pulmonary alveolar macrophages.
    Hengst JC; Kan-Mitchell J; Kempf RA; Strumpf IJ; Sharma OP; Kortes VL; Mitchell MS
    Cancer Res; 1985 Jan; 45(1):459-63. PubMed ID: 3871173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biosynthesis of macrophage activation factor.
    Baliga BS; Rorher SD; Maumenee AE; Peterson RD
    Lymphokine Res; 1986; 5(2):141-56. PubMed ID: 3517510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppression of cytotoxic T lymphocytes by carrageenan-activated macrophage-like cells.
    Yung YP; Cudkowicz G
    J Immunol; 1978 Nov; 121(5):1990-7. PubMed ID: 309486
    [No Abstract]   [Full Text] [Related]  

  • 26. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection.
    Tsung K; Dolan JP; Tsung YL; Norton JA
    Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.
    Varesio L; Holden HT; Taramelli D
    J Immunol; 1980 Dec; 125(6):2810-7. PubMed ID: 6159423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional heterogeneity and T cell-dependent activation of macrophages from murine sarcoma virus (MSV)-induced tumors.
    Holden HT; Varesio L; Taniyama T; Puccetti P
    Adv Exp Med Biol; 1979; 121B():509-20. PubMed ID: 232622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro killing of S. mansoni schistosomula by lymphokine-activated mouse macrophages.
    Bout DT; Joseph M; David JR; Capron AR
    J Immunol; 1981 Jul; 127(1):1-5. PubMed ID: 7240738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide production by splenic macrophages is not responsible for T cell suppression during acute infection with lactate dehydrogenase-elevating virus.
    Rowland RR; Butz EA; Plagemann PG
    J Immunol; 1994 Jun; 152(12):5785-95. PubMed ID: 8207208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perforin-dependent cytotoxic activity and lymphokine secretion by CD4+ T cells are regulated by CD8+ T cells.
    Williams NS; Engelhard VH
    J Immunol; 1997 Sep; 159(5):2091-9. PubMed ID: 9278294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2.
    Taffet SM; Pace JL; Russell SW
    J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of T cell-activating monokine of guinea pig macrophages induced by MDP and partial characterization of the monokine.
    Iribe H; Koga T; Onoue K
    J Immunol; 1982 Sep; 129(3):1029-32. PubMed ID: 6980914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alveolar macrophages. VI. Regulation of alveolar macrophage-mediated suppression of lymphocyte proliferation by a putative T cell.
    Warner LA; Holt PG; Mayrhofer G
    Immunology; 1981 Jan; 42(1):137-47. PubMed ID: 6970172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulatory activity of curcumin: suppression of lymphocyte proliferation, development of cell-mediated cytotoxicity, and cytokine production in vitro.
    Gao X; Kuo J; Jiang H; Deeb D; Liu Y; Divine G; Chapman RA; Dulchavsky SA; Gautam SC
    Biochem Pharmacol; 2004 Jul; 68(1):51-61. PubMed ID: 15183117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of a human lymphokine which renders macrophages cytotoxic.
    Gougerot MA; Dimitriu A; Dy M; Legrand L; Hamburger J
    Ann Immunol (Paris); 1977; 128C(3):621-32. PubMed ID: 141238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stress-induced effects on integral immune components involved in herpes simplex virus (HSV)-specific memory cytotoxic T lymphocyte activation.
    Bonneau RH
    Brain Behav Immun; 1996 Jun; 10(2):139-63. PubMed ID: 8811937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of lymphokine production by macrophages infiltrating murine virus-induced tumors.
    Varesio L; Herberman RB; Gerson JM; Holden HT
    Int J Cancer; 1979 Jul; 24(1):97-102. PubMed ID: 314424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.